1. Home
  2. POAS vs NSRX Comparison

POAS vs NSRX Comparison

Compare POAS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$2.49

Market Cap

22.9M

Sector

Industrials

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$2.75

Market Cap

25.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POAS
NSRX
Founded
2017
2019
Country
Singapore
Israel
Employees
N/A
7
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
25.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POAS
NSRX
Price
$2.49
$2.75
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
1.3M
129.9K
Earning Date
05-21-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$1.98
52 Week High
$7.40
$9.99

Technical Indicators

Market Signals
Indicator
POAS
NSRX
Relative Strength Index (RSI) 61.82 43.23
Support Level $1.40 $2.41
Resistance Level $3.84 $3.48
Average True Range (ATR) 0.15 0.30
MACD 0.02 -0.01
Stochastic Oscillator 82.45 20.56

Price Performance

Historical Comparison
POAS
NSRX

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: